Search clinical trials for: valsartan/atenolol

Total 579 results

HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

Hypertension | Hyperlipidemia

Korea, Republic of
Pachankis, Yang I., M.D.
First Affiliated Hospital of Chongqing Medical University

Completed

Detoxification From the Lipid Tract

COVID-19 Vaccine Adverse Reaction

China
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Terminated

The Confirmatory Olmesartan Plaque Regression Study (CONFIRM)

Essential Hypertension | Carotid Plaque

Italy
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Hypertension in Hemodialysis Patients (Aim 3)

Hypertension | Hemodialysis | Left Ventricular Hypertrophy

United States
Bristol-Myers Squibb
Pfizer

Completed

Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects

N/A - Healthy Subjects

United States
University of Vigo
Servicio Gallego de Salud

Completed

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (HYGIA)

Stroke | Cardiovascular Disease | Chronic Kidney Disease | Essential Hypertension

Spain
University Hospital Ostrava

Not yet recruiting

Determination of Drug Levels for Pharmacotherapy of Heart Failure

Cardiovascular Diseases | Heart Failure With Reduced Ejection Fraction

Czechia
Yonsei University

Completed

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

Hypertension

Korea, Republic of
University of Texas Southwestern Medical Center
Novartis Pharmaceuticals

Withdrawn

Regression of Fatty Heart by Valsartan Therapy

Metabolic Syndrome | Lipotoxicity

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine

Essential Hypertension

Taiwan, Japan, Philippines, China, Korea, Republic of, Malaysia
Gulhane School of Medicine

Completed

The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

Hypertension | Diabetes | Proteinuria

Turkey
Shiga University

Unknown

Rationale and Design for Shiga Microalbuminuria Reduction Trial

Hypertension | Diabetes Mellitus | Albuminuria

Japan
KU Leuven
University of Yaounde; University of Kinshasa; Yaounde Central Hospital; University... and other collaborators

Completed

Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial (NOAAH)

Blood Pressure

Cameroon, Côte D'Ivoire, Gabon, Nigeria, Senegal
University of Florida

Completed

Pharmacogenomic Evaluation of Antihypertensive Responses

Hypertension

United States
James A. Tumlin, MD
Nelson Kopyt, MD

Recruiting

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy (MRA-ACE)

Renal Insufficiency, Chronic | Diabetic Nephropathy Type 2

United States
Eisai Inc.
Eisai Co., Ltd.

Completed

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

High Blood Pressure

Taiwan
Weill Medical College of Cornell University
The New York Community Trust

Completed

Impact of Beta-blockers on Physical Function in HFpEF

Heart Failure | Heart Disease | Heart Failure, Diastolic | Heart Failure With Preserved Ejection Fraction | Cardiac Failure

United States
Novartis Pharmaceuticals

Completed

Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

Hypertension

France, Tunisia
Daiichi Sankyo, Inc.

Completed

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Hypertension | Metabolic Syndrome | Insulin Resistance

United States
Asan Medical Center
Yuhan Corporation

Completed

Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension

Hypertension

Korea, Republic of
HK inno.N Corporation

Completed

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

Hypertension | Hyperlipidemias

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY900020 in Healthy Chinese Participants

Healthy

Singapore
Creighton University

Completed

Black Education and Treatment of Hypertension (BEAT HTN) (BEAT)

Hypertension

United States
Sherwood Brown, MD, PhD
University of Miami; University of Texas Rio Grande Valley

Completed

Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

Bipolar Disorder | Alcohol Use Disorder

United States
Nagoya University

Completed

Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

Hypertension | Type 2 Diabetes Mellitus

Japan
Gachon University Gil Medical Center

Completed

Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris

Stable Angina Pectoris

Korea, Republic of
University of Virginia
Novo Nordisk A/S

Unknown

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

Healthy

United States
Novartis Pharmaceuticals

Completed

Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

Hypertension | Concurrent Obesity

Germany, Netherlands
Novartis Pharmaceuticals

Withdrawn

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Hypertension
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Hypertension

Japan
AstraZeneca

Terminated

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia (STABILIZE-CKD)

Renal Insufficiency, Chronic | Hyperkalemia

United States, Italy, Spain, Thailand, Vietnam, Turkey, Canada, Philippines, China, Malaysia, Taiwan, Brazil, Japan, Bulgaria, Russian Federation, Poland, Argentina, Mexico, Ukraine, India, Puerto Rico
Chipscreen Biosciences, Ltd.

Completed

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

T2DM

China
LG Chem

Completed

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

Healthy Male Volunteers

Korea, Republic of
Yale University

Recruiting

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Heart Failure

United States
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France

Terminated

Intermittent Hypoxia 2: Cardiovascular and Metabolism (IH2)

Hypoxia | Obstructive Sleep Apnea | Sleep Apnea

France
Cardiff University

Completed

Comparison of Medical Therapies in Marfan Syndrome.

Marfan Syndrome

United Kingdom
Mylan Bertek Pharmaceuticals

Completed

A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

Hypertension

United States
HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Healthy Male Subjects

Korea, Republic of
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Lymphoma

United States
The George Institute

Completed

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)

COVID-19 | Coronavirus Disease 2019

Australia, India
HK inno.N Corporation

Completed

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

Healthy

Korea, Republic of
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Terminated

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? (ARBs CORONA II)

Covid19 | SARS-CoV Infection

Canada, France
HK inno.N Corporation

Unknown

Bioequivalence Study of CJ-30060 in Healthy Volunteers

Healthy Subjects

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Essential Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
Ludwig-Maximilians - University of Munich
Maastricht University Medical Center; UMC Utrecht; University of Oxford; University...

Terminated

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function (TREAT-SVDs)

Cerebral Small Vessel Diseases

Netherlands, Germany, United Kingdom
Amgen

Terminated

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

United States, Sweden, Spain, United Kingdom, Australia, Denmark
Sunovion

Completed

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects

Asthma

United States
LG Life Sciences

Completed

Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

Hypertension, Hyperlipidemia

Korea, Republic of
M.D. Anderson Cancer Center

Terminated

Multimodal Treatment Strategy for Cancer Cachexia

Cachexia | Advanced Cancer

United States
Yan Li

Recruiting

Morning Versus Bedtime Dosing of Antihypertensive Medication

Hypertension | Blood Pressure | Drug Use

China

Search clinical trials for: valsartan/atenolol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations